nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—ABCC8—brainstem—Parkinson's disease	0.00423	0.0728	CbGeAlD
Gliclazide—ABCC8—forebrain—Parkinson's disease	0.00408	0.0703	CbGeAlD
Gliclazide—VEGFA—spinal cord—Parkinson's disease	0.00399	0.0687	CbGeAlD
Gliclazide—KCNJ11—cardiovascular system—Parkinson's disease	0.00375	0.0645	CbGeAlD
Gliclazide—ABCC8—cardiovascular system—Parkinson's disease	0.00345	0.0594	CbGeAlD
Gliclazide—VEGFA—cerebellum—Parkinson's disease	0.00316	0.0545	CbGeAlD
Gliclazide—ABCC8—medulla oblongata—Parkinson's disease	0.00295	0.0508	CbGeAlD
Gliclazide—ABCC8—midbrain—Parkinson's disease	0.00269	0.0464	CbGeAlD
Gliclazide—ABCC8—spinal cord—Parkinson's disease	0.00263	0.0453	CbGeAlD
Gliclazide—VEGFA—brain—Parkinson's disease	0.00257	0.0443	CbGeAlD
Gliclazide—KCNJ11—head—Parkinson's disease	0.00254	0.0437	CbGeAlD
Gliclazide—KCNJ11—nervous system—Parkinson's disease	0.0024	0.0414	CbGeAlD
Gliclazide—ABCC8—head—Parkinson's disease	0.00234	0.0402	CbGeAlD
Gliclazide—KCNJ11—central nervous system—Parkinson's disease	0.00232	0.0399	CbGeAlD
Gliclazide—KCNJ11—cerebellum—Parkinson's disease	0.00226	0.039	CbGeAlD
Gliclazide—ABCC8—nervous system—Parkinson's disease	0.00221	0.0381	CbGeAlD
Gliclazide—ABCC8—central nervous system—Parkinson's disease	0.00213	0.0367	CbGeAlD
Gliclazide—ABCC8—cerebellum—Parkinson's disease	0.00208	0.0359	CbGeAlD
Gliclazide—KCNJ11—brain—Parkinson's disease	0.00184	0.0317	CbGeAlD
Gliclazide—ABCC8—brain—Parkinson's disease	0.00169	0.0292	CbGeAlD
Gliclazide—CYP2C9—cardiovascular system—Parkinson's disease	0.00154	0.0266	CbGeAlD
Gliclazide—ALB—brain—Parkinson's disease	0.00121	0.0209	CbGeAlD
Gliclazide—VEGFA—Signaling Pathways—GPR37—Parkinson's disease	0.00102	0.00109	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—DGKQ—Parkinson's disease	0.00102	0.00109	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000996	0.00106	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000963	0.00102	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000956	0.00101	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—IL1B—Parkinson's disease	0.000949	0.00101	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000936	0.000994	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000932	0.00099	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000923	0.00098	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000923	0.00098	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—SOD1—Parkinson's disease	0.000911	0.000967	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000887	0.000941	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—ABL1—Parkinson's disease	0.000886	0.000941	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	0.000886	0.00094	CbGpPWpGaD
Gliclazide—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000873	0.000927	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—IL6—Parkinson's disease	0.00087	0.000924	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—ABL1—Parkinson's disease	0.000869	0.000923	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IGF2—Parkinson's disease	0.000865	0.000919	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—MAPK8—Parkinson's disease	0.000861	0.000914	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000857	0.00091	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—FGB—Parkinson's disease	0.00084	0.000892	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—DDC—Parkinson's disease	0.000836	0.000888	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000831	0.000882	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000825	0.000876	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—INS—Parkinson's disease	0.000822	0.000872	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—IL6—Parkinson's disease	0.000821	0.000872	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RIT2—Parkinson's disease	0.000819	0.000869	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—HGF—Parkinson's disease	0.000817	0.000868	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—DDC—Parkinson's disease	0.000811	0.000861	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	0.00081	0.00086	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.000808	0.000857	CbGpPWpGaD
Gliclazide—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000799	0.000848	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000798	0.000847	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000797	0.000847	CbGpPWpGaD
Gliclazide—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000796	0.000846	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GSTA4—Parkinson's disease	0.00079	0.000839	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GRK5—Parkinson's disease	0.000776	0.000824	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL1B—Parkinson's disease	0.000772	0.000819	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GSTA4—Parkinson's disease	0.000766	0.000813	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000741	0.000786	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.000739	0.000784	CbGpPWpGaD
Gliclazide—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000728	0.000773	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PLA2G6—Parkinson's disease	0.000711	0.000755	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—MAOB—Parkinson's disease	0.000704	0.000747	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GRM4—Parkinson's disease	0.000696	0.000739	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PLA2G6—Parkinson's disease	0.00069	0.000732	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—TNF—Parkinson's disease	0.000688	0.000731	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—MAG—Parkinson's disease	0.000687	0.000729	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—MAOB—Parkinson's disease	0.000683	0.000725	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000678	0.00072	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000675	0.000717	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—COMT—Parkinson's disease	0.000671	0.000713	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	0.000668	0.000709	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	0.000666	0.000708	CbGpPWpGaD
Gliclazide—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	0.000662	0.000703	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—MAPK8—Parkinson's disease	0.000661	0.000702	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PENK—Parkinson's disease	0.00066	0.0007	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MAG—Parkinson's disease	0.00066	0.0007	CbGpPWpGaD
Gliclazide—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000659	0.000699	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000643	0.000683	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000632	0.000671	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	0.000624	0.000662	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.000614	0.000652	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.000613	0.000651	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.000612	0.00065	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.000609	0.000647	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.000608	0.000645	CbGpPWpGaD
Gliclazide—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000605	0.000643	CbGpPWpGaD
Gliclazide—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.000604	0.000641	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PDYN—Parkinson's disease	0.000603	0.000641	CbGpPWpGaD
Gliclazide—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000601	0.000638	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	0.000593	0.000629	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—INS—Parkinson's disease	0.000586	0.000622	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GFAP—Parkinson's disease	0.000567	0.000602	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GRM5—Parkinson's disease	0.000561	0.000596	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TNF—Parkinson's disease	0.00056	0.000595	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.00056	0.000594	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	0.00056	0.000594	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—IL6—Parkinson's disease	0.000555	0.00059	CbGpPWpGaD
Gliclazide—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000552	0.000586	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CYP2D6—Parkinson's disease	0.000523	0.000556	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000515	0.000547	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CTGF—Parkinson's disease	0.000514	0.000545	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CYP2D6—Parkinson's disease	0.000507	0.000539	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CTGF—Parkinson's disease	0.000498	0.000529	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FGF20—Parkinson's disease	0.000492	0.000522	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00049	0.00052	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MCCC1—Parkinson's disease	0.000485	0.000515	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ND3—Parkinson's disease	0.000485	0.000515	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CYP2E1—Parkinson's disease	0.000479	0.000508	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ADORA2A—Parkinson's disease	0.000477	0.000506	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NQO1—Parkinson's disease	0.000473	0.000502	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—TH—Parkinson's disease	0.000466	0.000495	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CYP2E1—Parkinson's disease	0.000464	0.000493	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000462	0.000491	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NQO1—Parkinson's disease	0.000459	0.000487	CbGpPWpGaD
Gliclazide—ALB—Metabolism—TALDO1—Parkinson's disease	0.000456	0.000484	CbGpPWpGaD
Gliclazide—ALB—Metabolism—OMD—Parkinson's disease	0.000456	0.000484	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—TH—Parkinson's disease	0.000452	0.00048	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL6—Parkinson's disease	0.000452	0.00048	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000451	0.000478	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CYCS—Parkinson's disease	0.000448	0.000475	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	0.000445	0.000472	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—INSR—Parkinson's disease	0.00044	0.000467	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ND3—Parkinson's disease	0.000435	0.000462	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MCCC1—Parkinson's disease	0.000435	0.000462	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CYCS—Parkinson's disease	0.000434	0.000461	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—FGB—Parkinson's disease	0.000433	0.00046	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NDUFB11—Parkinson's disease	0.000432	0.000459	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—IL6—Parkinson's disease	0.000422	0.000448	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000421	0.000447	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FGB—Parkinson's disease	0.000416	0.000442	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR1A—Parkinson's disease	0.000414	0.000439	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GCH1—Parkinson's disease	0.000412	0.000438	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—TALDO1—Parkinson's disease	0.000409	0.000434	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—OMD—Parkinson's disease	0.000409	0.000434	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TAC1—Parkinson's disease	0.000408	0.000433	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—DRD1—Parkinson's disease	0.0004	0.000424	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MCCC1—Parkinson's disease	0.000397	0.000421	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ND3—Parkinson's disease	0.000397	0.000421	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—COMT—Parkinson's disease	0.000397	0.000421	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GSTP1—Parkinson's disease	0.000395	0.000419	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—MAOA—Parkinson's disease	0.000394	0.000418	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—HMOX1—Parkinson's disease	0.000389	0.000413	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	0.000388	0.000412	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—DRD3—Parkinson's disease	0.000387	0.000411	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—COMT—Parkinson's disease	0.000385	0.000408	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GSTP1—Parkinson's disease	0.000383	0.000406	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—MAOA—Parkinson's disease	0.000382	0.000405	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—HMOX1—Parkinson's disease	0.000377	0.000401	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ABCB1—Parkinson's disease	0.000374	0.000397	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—TALDO1—Parkinson's disease	0.000373	0.000396	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—OMD—Parkinson's disease	0.000373	0.000396	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000372	0.000395	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GCH1—Parkinson's disease	0.00037	0.000393	CbGpPWpGaD
Gliclazide—ALB—Metabolism—FBP1—Parkinson's disease	0.000367	0.00039	CbGpPWpGaD
Gliclazide—ALB—Metabolism—DBH—Parkinson's disease	0.000367	0.00039	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GBA—Parkinson's disease	0.000367	0.00039	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GSTM1—Parkinson's disease	0.000363	0.000385	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ABCB1—Parkinson's disease	0.000362	0.000385	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ADRBK1—Parkinson's disease	0.000362	0.000384	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000359	0.000381	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—IL6—Parkinson's disease	0.000359	0.000381	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	0.000354	0.000376	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GSTM1—Parkinson's disease	0.000352	0.000373	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR7—Parkinson's disease	0.00035	0.000372	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—DRD2—Parkinson's disease	0.00035	0.000372	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GPX1—Parkinson's disease	0.000347	0.000369	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GCH1—Parkinson's disease	0.000337	0.000358	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GPX1—Parkinson's disease	0.000337	0.000358	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000334	0.000354	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—FBP1—Parkinson's disease	0.00033	0.00035	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—DBH—Parkinson's disease	0.00033	0.00035	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GBA—Parkinson's disease	0.00033	0.00035	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SOD1—Parkinson's disease	0.000322	0.000341	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000321	0.000341	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—MTHFR—Parkinson's disease	0.000321	0.00034	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TNF—Parkinson's disease	0.000317	0.000337	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—MTHFR—Parkinson's disease	0.000311	0.00033	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000308	0.000327	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—ABL1—Parkinson's disease	0.000307	0.000326	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IGF2—Parkinson's disease	0.000305	0.000324	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000304	0.000323	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—DBH—Parkinson's disease	0.000301	0.000319	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—FBP1—Parkinson's disease	0.000301	0.000319	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GBA—Parkinson's disease	0.000301	0.000319	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—APOE—Parkinson's disease	0.000298	0.000317	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IGF2—Parkinson's disease	0.000293	0.000311	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—APOE—Parkinson's disease	0.000289	0.000307	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—HGF—Parkinson's disease	0.000288	0.000306	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IGF1R—Parkinson's disease	0.000284	0.000301	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EDN1—Parkinson's disease	0.00028	0.000298	CbGpPWpGaD
Gliclazide—ALB—Metabolism—DDC—Parkinson's disease	0.00027	0.000286	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000268	0.000284	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NGF—Parkinson's disease	0.000258	0.000273	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000257	0.000273	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—IL6—Parkinson's disease	0.000256	0.000272	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—INS—Parkinson's disease	0.000255	0.000271	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GSTA4—Parkinson's disease	0.000255	0.00027	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000251	0.000267	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—INS—Parkinson's disease	0.000247	0.000262	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR2A—Parkinson's disease	0.000245	0.00026	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—DDC—Parkinson's disease	0.000242	0.000257	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PLA2G6—Parkinson's disease	0.000229	0.000243	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GSTA4—Parkinson's disease	0.000229	0.000243	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—APOE—Parkinson's disease	0.000228	0.000242	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MAOB—Parkinson's disease	0.000227	0.000241	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000226	0.00024	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—DDC—Parkinson's disease	0.000221	0.000234	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000216	0.000229	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GSTA4—Parkinson's disease	0.000208	0.000221	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	0.000206	0.000219	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000206	0.000219	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MAOB—Parkinson's disease	0.000204	0.000216	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—INS—Parkinson's disease	0.000195	0.000207	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000194	0.000206	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	0.000188	0.000199	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MAOB—Parkinson's disease	0.000186	0.000197	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000177	0.000188	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP2D6—Parkinson's disease	0.000169	0.000179	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CTGF—Parkinson's disease	0.000166	0.000176	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP2E1—Parkinson's disease	0.000154	0.000164	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NQO1—Parkinson's disease	0.000153	0.000162	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	0.000151	0.000161	CbGpPWpGaD
Gliclazide—ALB—Metabolism—TH—Parkinson's disease	0.00015	0.00016	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CTGF—Parkinson's disease	0.000149	0.000158	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CASP3—Parkinson's disease	0.000145	0.000154	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYCS—Parkinson's disease	0.000144	0.000153	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	0.000139	0.000147	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	0.000138	0.000147	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NQO1—Parkinson's disease	0.000137	0.000145	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CTGF—Parkinson's disease	0.000136	0.000144	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—TH—Parkinson's disease	0.000135	0.000143	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MAPK8—Parkinson's disease	0.000133	0.000141	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYCS—Parkinson's disease	0.00013	0.000138	CbGpPWpGaD
Gliclazide—ALB—Metabolism—COMT—Parkinson's disease	0.000128	0.000136	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GSTP1—Parkinson's disease	0.000127	0.000135	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MAOA—Parkinson's disease	0.000127	0.000135	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	0.000126	0.000134	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HMOX1—Parkinson's disease	0.000126	0.000133	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NQO1—Parkinson's disease	0.000125	0.000133	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—TH—Parkinson's disease	0.000123	0.000131	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ABCB1—Parkinson's disease	0.00012	0.000128	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYCS—Parkinson's disease	0.000118	0.000125	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GSTM1—Parkinson's disease	0.000117	0.000124	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—COMT—Parkinson's disease	0.000115	0.000122	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GSTP1—Parkinson's disease	0.000114	0.000121	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MAOA—Parkinson's disease	0.000114	0.000121	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HMOX1—Parkinson's disease	0.000113	0.00012	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GPX1—Parkinson's disease	0.000112	0.000119	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ABCB1—Parkinson's disease	0.000108	0.000115	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GSTM1—Parkinson's disease	0.000105	0.000111	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—COMT—Parkinson's disease	0.000105	0.000111	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GSTP1—Parkinson's disease	0.000104	0.000111	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MAOA—Parkinson's disease	0.000104	0.00011	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MTHFR—Parkinson's disease	0.000103	0.00011	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HMOX1—Parkinson's disease	0.000103	0.000109	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GPX1—Parkinson's disease	0.000101	0.000107	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ABCB1—Parkinson's disease	9.86e-05	0.000105	CbGpPWpGaD
Gliclazide—ALB—Metabolism—APOE—Parkinson's disease	9.62e-05	0.000102	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GSTM1—Parkinson's disease	9.57e-05	0.000102	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MTHFR—Parkinson's disease	9.28e-05	9.85e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GPX1—Parkinson's disease	9.17e-05	9.73e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—APOE—Parkinson's disease	8.64e-05	9.17e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6—Parkinson's disease	8.51e-05	9.03e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MTHFR—Parkinson's disease	8.46e-05	8.98e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—INS—Parkinson's disease	8.22e-05	8.73e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—APOE—Parkinson's disease	7.88e-05	8.36e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—INS—Parkinson's disease	7.38e-05	7.83e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—INS—Parkinson's disease	6.73e-05	7.14e-05	CbGpPWpGaD
